Skip to main content

Pharma News

pharma courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • The Drug Controller General of India (DCGI) on relaxed guidelines for the production of pediatric HIV drugs, whose supply was affected by regulatory issues. The regulator approved the child-friendly and thermally stable pellet formulation of Lopinavir / Ritonavir without feasibility studies, but said it would control post-marketing surveillance.

  • Zydus Cadila has informed that the USFDA has given final approval to market Mesalamine Delayed- Release Tablets USP, 1.2 g in the US market. Zydus Cadila was the first to file an Abbreviated New Drug Application (ANDA) for a generic version of Lialda® (mesalamine).

  • AstraZeneca and its global biologics research and development arm, MedImmune, will present the latest research from the Company’s Cardiovascular and Metabolic Diseases (CVMD) therapy area, including for Farxiga (dapagliflozin) and Bydureon (exenatide extended-release) for injectable suspension, with more than 50 abstracts at the American Diabetes Association’s (ADA) 77th Scientific Sessions in San Diego, USA 9-13 June 2017.

  • The government of Punjab will establish two 50-bed Ayush hospitals in the state, Health Minister Brahm Mohindra said. Standardized services of Ayurveda, Yoga, Naturopathy, Unani, Siddha and Homeopathy would also be provided to patients indoors and outdoors in these hospitals, he added.

    [adsense:336x280:8701650588]

  • Government of Assam and Tata Trusts, signed a Memorandum of Understanding to provide comprehensive cancer care and ensure affordable quality treatment for cancer patients in the state. Assam is one of the states that has the highest per capita cancer burden in India. The Memorandum of Understanding was signed under the presence of Shri. Himanta Biswa Sarma, Hon’ble Minister of Health and Family Welfare, Government of Assam along with R. Venkataramanan, Managing Trustee, Tata Trusts.

  • Tobacco and other tobacco use kill more than seven million people each year, the World Health Organization (WHO) said, also warning of the environmental impact of tobacco production, distribution and waste.

  • Almost 40% of Ayurveda products, including Baba Ramdev's Patanjali articles, were found inferior by Haridwar's Ayurveda and Unani's Office, a revealed Right to Information (RTI) response.Out of the 82 samples collected between 2013 and 2016, 32 failed the quality test.

Subscribe to Pharma News